Composition
- Active ingredients
- ISRADIPINE 10MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- ISRADIPINE 2.5MG · CapsuleANDA077169-001 · Prescription
- ISRADIPINE 5MG · CapsuleANDA077169-002 · Prescription
- ISRADIPINE 10MG · Tablet, extended releaseThis page
- ISRADIPINE 5MG · Tablet, extended releaseANDA201067-001 · Discontinued
- ISRADIPINE 2.5MG · CapsuleANDA077317-001 · Prescription
- ISRADIPINE 5MG · CapsuleANDA077317-002 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA201067.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Isradipine
- Route
- Oral
- Dosage form
- Tablet, extended release
- Applicant
- Pharmobedient
- Status
- Discontinued
- FDA approval
- 27 Nov 2015
- Application
- ANDA201067-002